Effect of Yashtimadhu in Asthibhagna(Fracture)

A Randomised Controlled Clinical Trial To Study The Effect Of Yashtimadhu in Asthibhagna With Special Reference To Closed Undisplaced Fracture - NIL

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/08/072255

Enrollment

Registered

2024-08-09

Start date

Unknown

Completion date

Unknown

Last updated

2024-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M843- Stress fracture

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients will be selected Irrespective of caste, religion, gender and socio-economic status. 2) Patients with closed un-displaced (long bone) fractures will be Included.

Exclusion criteria

Exclusion criteria: 1) Patients other than closed un-dispaced fractures are excluded. 2) Patients with known case of Diabetes Mellitus, Hypertension will be excluded. 3) Patients with pathologiacal fracture like osteoporosis will excluded. 4) Fractures requiring open reduction and internal fixation. 5) Patients with previous non-union, metastatic tumor will be excluded.

Design outcomes

Primary

Measure	Time frame
Reduction in sign and symptoms of asthibhagna after ingestion of YashtimadhuTimepoint: For 25 days	—

Secondary

Measure	Time frame
Where The Trial Group Stands In Comparison With Control GroupTimepoint: 18 Months	—

Countries

India

Contacts

Public ContactDr Rahul Suresh Kokare

SMBT Ayurved College and Hospital

drdkumavat@gmail.com9049059799

Outcome results